【摘要】：基本藥物制度的實施旨在改變我國傳統(tǒng)藥品流通環(huán)節(jié)過長、層層加利的詬病，并且通過對整個醫(yī)藥流通環(huán)節(jié)各方面利益進行重新調(diào)節(jié)的方式來實現(xiàn)抑制藥價的目標。而基本藥物配送作為基本藥物制度實施過程中的關鍵環(huán)節(jié)，也直接關系著基本藥物制度的貫徹實施。因此，基本藥物的配送環(huán)節(jié)具有很重要的研究意義，但是目前國內(nèi)對基本藥物配送環(huán)節(jié)缺乏一個系統(tǒng)性的規(guī)定，且現(xiàn)階段我國在基本藥物配送環(huán)節(jié)中還存在許多問題亟待解決。本論文通過文獻研究、對比研究與實地調(diào)研相結(jié)合的方法對河南基本藥物配送模式進行了研究，繼而發(fā)現(xiàn)其中存在的問題與不足，借鑒國外先進方法和理念，，力爭去探究一個較為科學、合理的配送模式，以解決其中存在的弊端，便于河南及其他省份在不斷完善基本藥物配送政策時進行參考，也為更好的發(fā)展和完善我國基本藥物制度打下堅實的基礎。 本論文主要分為以下幾個章節(jié)： 第一章本論文的研究背景，對基本藥物制度、基本藥物配送、我國藥品流通狀況以及新版GSP實施的相關內(nèi)容進行了概述，此外還對河南省地理、人口、藥品流通狀況以及本論文的研究意義進行了簡單介紹。第二章對各個省份基本藥物集中采購及配送模式進行了對比分析，主要包括藥物的評標方式、質(zhì)量層次區(qū)分、配送參與模式、藥物采購頻率及配送時間的要求、相關配送費用和藥款支付方式方面的對比，并分析這些差別背后的原因，最后羅列出配送環(huán)節(jié)中存在的一些問題，就出現(xiàn)問題的深層次原因進行探究。第三章則主要對河南省基本藥物配送情況深入介紹，分別從河南省實施基本藥物制度的范圍、基本藥物采購方法及周期、評標方式等內(nèi)容進行較為詳細的闡述，挖掘出河南省基本藥物采購中的優(yōu)點及創(chuàng)新點。第四章首先對基本藥物配送成本構(gòu)成相關內(nèi)容進行描述，然后將其與我省具體情況相結(jié)合設計出了調(diào)查表，并向相關企業(yè)發(fā)放了該問卷。通過匯總、整合這些問卷得出調(diào)查結(jié)果。最后為探究基本藥物配送費用的合理與否，將配送企業(yè)與物流公司的配送費用進行了比較。第五章主要探討了美國、日本、以及歐盟關于醫(yī)藥流通方面的經(jīng)驗。第六章針對河南省基本藥物配送過程中存在的問題，在認真分析、總結(jié)相關內(nèi)容并借鑒國外先進經(jīng)驗的基礎上，提出了促進我省基本藥物配送發(fā)展的一些建議，包括加快醫(yī)藥流通企業(yè)的整合率；出臺相關政策和法律；引入競爭機制以及大力發(fā)展第三方物流等建議。第七章是結(jié)論部分，對全文進行了總結(jié)。
[Abstract]:The implementation of the basic drug system aims to change the traditional drug circulation link in our country, which is criticized by Ghali layer by layer, and to achieve the goal of restraining the drug price by re-adjusting the interests of all aspects of the whole medicine circulation link. The delivery of essential drugs, as a key link in the implementation of the basic drug system, is also directly related to the implementation of the basic drug system. Therefore, the distribution of essential drugs has a very important research significance, but at present there is a lack of a systematic regulation on the distribution of essential drugs in our country, and there are still many problems to be solved in the distribution of essential drugs in our country at present. By means of literature research, comparative research and field investigation, this paper studies the distribution mode of Henan essential drugs, and then finds the existing problems and shortcomings, and draws lessons from foreign advanced methods and concepts. Strive to explore a more scientific, reasonable distribution mode, in order to solve the shortcomings in order to facilitate Henan and other provinces in the continuous improvement of basic drug distribution policy for reference, It also lays a solid foundation for the better development and improvement of China's basic drug system. This paper is divided into the following chapters: chapter one: the research background of this paper, the basic drug system, the distribution of essential drugs, the distribution of drugs in China and the implementation of the new version of GSP related content are summarized. In addition, this paper briefly introduces the geography, population, drug circulation and the significance of this paper. The second chapter makes a comparative analysis of the modes of centralized procurement and distribution of essential drugs in various provinces, mainly including the evaluation of the bid for drugs, the distinction of quality levels, the mode of distribution participation, the frequency of drug procurement and the requirements of distribution time. This paper analyzes the reasons behind these differences, lists some problems existing in the distribution process, and probes into the deep-seated causes of the problems. The third chapter mainly introduces the distribution of essential drugs in Henan Province, respectively from the scope of the implementation of the essential drugs system in Henan Province, the procurement methods and cycles of essential drugs, and the way of bid evaluation, and so on, and so on. The advantages and innovations in the procurement of essential drugs in Henan Province are excavated. The fourth chapter first describes the basic drug distribution cost components, and then designs the questionnaire combined with the specific situation of our province, and issues the questionnaire to the relevant enterprises. Through the summary, integrate these questionnaires to arrive at the results of the survey. Finally, the distribution costs of distribution enterprises and logistics companies are compared in order to explore the rationality of distribution costs of essential drugs. The fifth chapter mainly discusses the experience of the United States, Japan and the European Union on the circulation of medicine. In the sixth chapter, aiming at the problems existing in the distribution of essential drugs in Henan Province, on the basis of careful analysis, summing up the relevant contents and drawing lessons from the advanced experience of foreign countries, some suggestions are put forward to promote the development of the distribution of essential drugs in Henan Province. Including speeding up the integration rate of pharmaceutical circulation enterprises; Introduction of relevant policies and laws; introduction of competition mechanisms and vigorous development of third-party logistics and other recommendations. The seventh chapter is the conclusion part, has carried on the summary to the full text.
【學位授予單位】：鄭州大學
【學位級別】：碩士
【學位授予年份】：2014
【分類號】：R95

【參考文獻】

相關期刊論文 前10條

1 趙云;徐義海;農(nóng)圣;廖滿媚;;公立醫(yī)院公益性本質(zhì)內(nèi)涵和實現(xiàn)路徑爭議的反思及重構(gòu)[J];現(xiàn)代醫(yī)院管理;2011年03期

2 張露月;;關于藥品物流配送成本研究[J];商業(yè)文化(上半月);2012年04期

3 黃新謀;;我國藥品物流運作模式分析[J];企業(yè)導報;2012年17期

4 周正韋;徐懷伏;;我國基本藥物配送政策現(xiàn)狀研究[J];現(xiàn)代商貿(mào)工業(yè);2012年03期

5 姚瑤;肖宏浩;;關于當前基本藥物配送的一些探討[J];江西中醫(yī)學院學報;2010年06期

6 李浩娜;史學紅;劉紅兵;馬承嚴;;郵政藥品物流問題探討[J];醫(yī)藥導報;2011年06期

7 高劍鋒;方翰林;肖敏;廖駿;;對基本藥物招標采購制度的思考[J];中國藥業(yè);2011年22期

8 楊林;羅敏;金朝輝;李天平;胡明;徐s

本文編號：2472553